{"organizations": [], "uuid": "1c39e02de9e3a76f2119e5ad2032c2ed3735cb1f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180517.html", "section_title": "Archive News &amp; Video for Thursday, 17 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biodelivery-sciences-announces-pri/brief-biodelivery-sciences-announces-pricing-of-50-million-equity-financing-idUSASC0A2RX", "country": "US", "domain_rank": 408, "title": "BRIEF-BioDelivery Sciences Announces Pricing Of $50 Million Equity Financing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-17T20:38:00.000+03:00", "replies_count": 0, "uuid": "1c39e02de9e3a76f2119e5ad2032c2ed3735cb1f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biodelivery-sciences-announces-pri/brief-biodelivery-sciences-announces-pricing-of-50-million-equity-financing-idUSASC0A2RX", "ord_in_thread": 0, "title": "BRIEF-BioDelivery Sciences Announces Pricing Of $50 Million Equity Financing", "locations": [], "entities": {"persons": [], "locations": [{"name": "biodelivery", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-biodelivery sciences", "sentiment": "negative"}, {"name": "biodelivery sciences international inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 17 (Reuters) - BioDelivery Sciences International Inc :\n* BIODELIVERY SCIENCES ANNOUNCES PRICING OF $50 MILLION EQUITY FINANCING\n* BIODELIVERY SCIENCES INTERNATIONAL INC - SERIES B STOCK IS BEING SOLD FOR $10,000 PER SHARE\n* BIODELIVERY SCIENCES - EACH SHARE OF SERIES B STOCK WILL BE CONVERTIBLE INTO NUMBER OF SHARES OF COMMON STOCK DETERMINED BY DIVIDING $10,000 BY $1.80 Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-17T20:38:00.000+03:00", "crawled": "2018-05-18T19:41:33.041+03:00", "highlightTitle": ""}